跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BEACTAFED CO SYRUP - HSA Drug Approval Details
Approvals
/
HSA
/
BEACTAFED CO SYRUP
Approved
THERAPEUTIC
BEACTAFED CO SYRUP
BEACONS PHARMACEUTICALS PTE LTD (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
May 30, 1989
Approval ID
3cae086953218d19
Company
BEACONS PHARMACEUTICALS PTE LTD (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
3cae086953218d19
Drug Name
BEACTAFED CO SYRUP
Product Name
BEACTAFED CO SYRUP
Approval Number
SIN03140P
Approval Date
1989-05-30
Registrant
BEACONS PHARMACEUTICALS PTE. LTD.
Licence Holder
BEACONS PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R05DA20
Atc Item Name
combinations
Pharma Manufacturer Name
BEACONS PHARMACEUTICALS PTE. LTD.
Company Detail Path
/organization/beacons-pharmaceuticals-pte-ltd
Active Ingredients
CODEINE PHOSPHATE
10 mg/5 ml
TRIPROLIDINE HCl
1.25 mg/5 ml
PSEUDOEPHEDRINE HCl
32 mg/5 ml
CODEINE PHOSPHATE
10 mg/5 ml
PSEUDOEPHEDRINE HCl
32 mg/5 ml
TRIPROLIDINE HCl
1.25 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 30, 1989
Approval ID
3cae086953218d19
Type
Therapeutic
Back to HSA Approvals